FEN1 overexpression is correlated to cancer, and FEN1 is highly expressed in the cells of metastatic prostate cancer [22] , gastric cancer [23] , neuroblastomas [24], pancreatic cancer [25], lung cancer [26], and breast cancer [9, 10]. Here, FEN1 is linked to lung carcinoma.